MTOR and familial pancreatic carcinoma: Furthermore, it has recently been established that Orai1 inhibition, using the RP4010 CRAC channel inhibitor, decreased pancreatic cancer cell proliferation through the down-regulation of the AKT/mTOR signaling pathway [63].